Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Sep 15;102(6):1132–1141. doi: 10.1172/JCI2686

Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.

J Wang 1, K Palmer 1, J Lŏtvall 1, S Milan 1, X F Lei 1, K I Matthaei 1, J Gauldie 1, M D Inman 1, M Jordana 1, Z Xing 1
PMCID: PMC509096  PMID: 9739047

Abstract

IL-5 is induced locally in the lung and systemically in the circulation during allergic airways eosinophilic inflammation both in humans and experimental animals. However, the precise role of local and systemic IL-5 in the development of allergic airways eosinophilia remains to be elucidated. In our current study, we demonstrate that compared with their IL-5(+/+) counterparts, IL-5(-/-) mice lacked an IL-5 response both in the lung and peripheral blood, yet they released similar amounts of IL-4, eotaxin, and MIP-1alpha in the lung after ovalbumin (OVA) sensitization and challenge. At cellular levels, these mice failed to develop peripheral blood and airways eosinophilia while the responses of lymphocytes, neutrophils, and macrophages remained similar to those in IL-5(+/+) mice. To dissect the relative role of local and systemic IL-5 in this model, we constructed a gene transfer vector expressing murine IL-5. Intramuscular IL-5 gene transfer to OVA-sensitized IL-5(-/-) mice led to raised levels of IL-5 compartmentalized to the circulation and completely reconstituted airways eosinophilia upon OVA challenge, which was associated with reconstitution of eosinophilia in the bone marrow and peripheral blood. Significant airways eosinophilia was observed for at least 7 d in these mice. In contrast, intranasal IL-5 gene transfer, when rendered to give rise to a significant but compartmentalized level of transgene protein IL-5 in the lung, was unable to reconstitute airways eosinophilia in OVA-sensitized IL-5(-/-) mice upon OVA-challenge, which was associated with a lack of eosinophilic responses in bone marrow and peripheral blood. Our findings thus provide unequivocal evidence that circulating but not local lung IL-5 is critically required for the development of allergic airways eosinophilia. These findings also provide the rationale for developing strategies to target circulating IL-5 and/or its receptors in bone marrow to effectively control asthmatic airways eosinophilia.

Full Text

The Full Text of this article is available as a PDF (535.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander A. G., Barkans J., Moqbel R., Barnes N. C., Kay A. B., Corrigan C. J. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax. 1994 Dec;49(12):1231–1233. doi: 10.1136/thx.49.12.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baskin D. S., Browning J. L., Widmayer M. A., Zhu Z. Q., Grossman R. G. Development of a model for Parkinson's disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion. Life Sci. 1994;54(7):471–479. doi: 10.1016/0024-3205(94)00406-4. [DOI] [PubMed] [Google Scholar]
  3. Bochner B. S., Undem B. J., Lichtenstein L. M. Immunological aspects of allergic asthma. Annu Rev Immunol. 1994;12:295–335. doi: 10.1146/annurev.iy.12.040194.001455. [DOI] [PubMed] [Google Scholar]
  4. Clutterbuck E. J., Sanderson C. J. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL5): production of functionally active eosinophils from normal human bone marrow. Blood. 1988 Mar;71(3):646–651. [PubMed] [Google Scholar]
  5. Coffman R. L., Seymour B. W., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989 Jul 21;245(4915):308–310. doi: 10.1126/science.2787531. [DOI] [PubMed] [Google Scholar]
  6. Collins P. D., Marleau S., Griffiths-Johnson D. A., Jose P. J., Williams T. J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995 Oct 1;182(4):1169–1174. doi: 10.1084/jem.182.4.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dent L. A., Strath M., Mellor A. L., Sanderson C. J. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med. 1990 Nov 1;172(5):1425–1431. doi: 10.1084/jem.172.5.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Foster P. S., Hogan S. P., Ramsay A. J., Matthaei K. I., Young I. G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996 Jan 1;183(1):195–201. doi: 10.1084/jem.183.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ganzalo J. A., Jia G. Q., Aguirre V., Friend D., Coyle A. J., Jenkins N. A., Lin G. S., Katz H., Lichtman A., Copeland N. Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 1996 Jan;4(1):1–14. doi: 10.1016/s1074-7613(00)80293-9. [DOI] [PubMed] [Google Scholar]
  10. Hamelmann E., Oshiba A., Schwarze J., Bradley K., Loader J., Larsen G. L., Gelfand E. W. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol. 1997 Jun;16(6):674–682. doi: 10.1165/ajrcmb.16.6.9191469. [DOI] [PubMed] [Google Scholar]
  11. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A. J., Corrigan C. J., Bradley B., Durham S. R., Collins J. V., Jeffery P. K. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest. 1991 May;87(5):1541–1546. doi: 10.1172/JCI115166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kopf M., Brombacher F., Hodgkin P. D., Ramsay A. J., Milbourne E. A., Dai W. J., Ovington K. S., Behm C. A., Köhler G., Young I. G. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996 Jan;4(1):15–24. doi: 10.1016/s1074-7613(00)80294-0. [DOI] [PubMed] [Google Scholar]
  13. Kung T. T., Stelts D. M., Zurcher J. A., Adams G. K., 3rd, Egan R. W., Kreutner W., Watnick A. S., Jones H., Chapman R. W. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol. 1995 Sep;13(3):360–365. doi: 10.1165/ajrcmb.13.3.7654390. [DOI] [PubMed] [Google Scholar]
  14. Lamkhioued B., Renzi P. M., Abi-Younes S., Garcia-Zepada E. A., Allakhverdi Z., Ghaffar O., Rothenberg M. D., Luster A. D., Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997 Nov 1;159(9):4593–4601. [PubMed] [Google Scholar]
  15. Lang R. A., Metcalf D., Cuthbertson R. A., Lyons I., Stanley E., Kelso A., Kannourakis G., Williamson D. J., Klintworth G. K., Gonda T. J. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell. 1987 Nov 20;51(4):675–686. doi: 10.1016/0092-8674(87)90136-x. [DOI] [PubMed] [Google Scholar]
  16. Lee J. J., McGarry M. P., Farmer S. C., Denzler K. L., Larson K. A., Carrigan P. E., Brenneise I. E., Horton M. A., Haczku A., Gelfand E. W. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 1997 Jun 16;185(12):2143–2156. doi: 10.1084/jem.185.12.2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee N. A., McGarry M. P., Larson K. A., Horton M. A., Kristensen A. B., Lee J. J. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol. 1997 Feb 1;158(3):1332–1344. [PubMed] [Google Scholar]
  18. Lei X. F., Ohkawara Y., Stämpfli M. R., Gauldie J., Croitoru K., Jordana M., Xing Z. Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin Exp Immunol. 1998 Aug;113(2):157–165. doi: 10.1046/j.1365-2249.1998.00652.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lei X. F., Ohkawara Y., Stämpfli M. R., Mastruzzo C., Marr R. A., Snider D., Xing Z., Jordana M. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest. 1998 Mar 15;101(6):1342–1353. doi: 10.1172/JCI1662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lukacs N. W., Strieter R. M., Warmington K., Lincoln P., Chensue S. W., Kunkel S. L. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol. 1997 May 1;158(9):4398–4404. [PubMed] [Google Scholar]
  21. MacLean J. A., Ownbey R., Luster A. D. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med. 1996 Oct 1;184(4):1461–1469. doi: 10.1084/jem.184.4.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mauser P. J., Pitman A. M., Fernandez X., Foran S. K., Adams G. K., 3rd, Kreutner W., Egan R. W., Chapman R. W. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med. 1995 Aug;152(2):467–472. doi: 10.1164/ajrccm.152.2.7633694. [DOI] [PubMed] [Google Scholar]
  23. McGrory W. J., Bautista D. S., Graham F. L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988 Apr;163(2):614–617. doi: 10.1016/0042-6822(88)90302-9. [DOI] [PubMed] [Google Scholar]
  24. Mould A. W., Matthaei K. I., Young I. G., Foster P. S. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest. 1997 Mar 1;99(5):1064–1071. doi: 10.1172/JCI119234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ohkawara Y., Lei X. F., Stämpfli M. R., Marshall J. S., Xing Z., Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol. 1997 May;16(5):510–520. doi: 10.1165/ajrcmb.16.5.9160833. [DOI] [PubMed] [Google Scholar]
  26. Resnick M. B., Weller P. F. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol. 1993 Apr;8(4):349–355. doi: 10.1165/ajrcmb/8.4.349. [DOI] [PubMed] [Google Scholar]
  27. Robinson D. S., Durham S. R., Kay A. B. Cytokines. 3. Cytokines in asthma. Thorax. 1993 Aug;48(8):845–853. doi: 10.1136/thx.48.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  29. Rothenberg M. E., MacLean J. A., Pearlman E., Luster A. D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med. 1997 Feb 17;185(4):785–790. doi: 10.1084/jem.185.4.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rothenberg M. E., Ownbey R., Mehlhop P. D., Loiselle P. M., van de Rijn M., Bonventre J. V., Oettgen H. C., Leder P., Luster A. D. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med. 1996 May;2(3):334–348. [PMC free article] [PubMed] [Google Scholar]
  31. Schleimer R. P., Sterbinsky S. A., Kaiser J., Bickel C. A., Klunk D. A., Tomioka K., Newman W., Luscinskas F. W., Gimbrone M. A., Jr, McIntyre B. W. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol. 1992 Feb 15;148(4):1086–1092. [PubMed] [Google Scholar]
  32. Sehmi R., Wood L. J., Watson R., Foley R., Hamid Q., O'Byrne P. M., Denburg J. A. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest. 1997 Nov 15;100(10):2466–2475. doi: 10.1172/JCI119789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Seminario M. C., Gleich G. J. The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol. 1994 Dec;6(6):860–864. doi: 10.1016/0952-7915(94)90005-1. [DOI] [PubMed] [Google Scholar]
  34. Tai P. C., Sun L., Spry C. J. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol. 1991 Aug;85(2):312–316. doi: 10.1111/j.1365-2249.1991.tb05725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Van Oosterhout A. J., Fattah D., Van Ark I., Hofman G., Buckley T. L., Nijkamp F. P. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J Allergy Clin Immunol. 1995 Jul;96(1):104–112. doi: 10.1016/s0091-6749(95)70039-0. [DOI] [PubMed] [Google Scholar]
  36. Walker C., Bode E., Boer L., Hansel T. T., Blaser K., Virchow J. C., Jr Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992 Jul;146(1):109–115. doi: 10.1164/ajrccm/146.1.109. [DOI] [PubMed] [Google Scholar]
  37. Wang J. M., Rambaldi A., Biondi A., Chen Z. G., Sanderson C. J., Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol. 1989 Apr;19(4):701–705. doi: 10.1002/eji.1830190420. [DOI] [PubMed] [Google Scholar]
  38. Wood L. J., Inman M. D., Watson R. M., Foley R., Denburg J. A., O'Byrne P. M. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med. 1998 Jan;157(1):99–105. doi: 10.1164/ajrccm.157.1.9704125. [DOI] [PubMed] [Google Scholar]
  39. Xing Z., Braciak T., Ohkawara Y., Sallenave J. M., Foley R., Sime P. J., Jordana M., Graham F. L., Gauldie J. Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation. J Leukoc Biol. 1996 Apr;59(4):481–488. doi: 10.1002/jlb.59.4.481. [DOI] [PubMed] [Google Scholar]
  40. Xing Z., Ohkawara Y., Jordana M., Graham F. L., Gauldie J. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther. 1997 Feb;4(2):140–149. doi: 10.1038/sj.gt.3300371. [DOI] [PubMed] [Google Scholar]
  41. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med. 1988 May 1;167(5):1737–1742. doi: 10.1084/jem.167.5.1737. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES